YCBD.AMEXCbdmd, INC

Form 4: cbdMD Director William F. Raines III Reports Acquisition and Disposal of Common Stock

Sentiment:

SEC Form 4


Director William F. Raines III reports acquiring 1,572 shares of cbdMD, Inc. common stock and disposing of 12,104 shares on May 16, 2025, according to a Form 4 filing.

Summary

  • William F. Raines III, a director of cbdMD, Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On May 16, 2025, Raines acquired 1,572 shares of common stock.
  • On the same day, Raines disposed of 12,104 shares of common stock.
  • Following these transactions, Raines beneficially owns 12,104 shares of common stock.
  • The acquisition was related to restricted stock units vesting quarterly, starting June 30, 2025, and ending March 31, 2026.
  • These restricted stock units were issued under the 2021 Equity Compensation Plan as compensation for services on the Board of Directors.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Future Outlook

The director's future holdings will be affected by the vesting schedule of the restricted stock units, which continues until March 31, 2026.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and provide transparency into their transactions in the company's stock. This filing indicates activity by a director related to compensation and stock unit vesting.

Comparison to Industry Standards

  • Comparing this filing to other Form 4 filings within the cannabis or CBD industry could provide context on executive compensation trends.
  • Companies like Canopy Growth Corporation, Tilray, or Cronos Group could be used as benchmarks for comparing equity compensation practices.
  • Analyzing the vesting schedules and amounts of restricted stock units granted to directors in these companies could offer insights into industry standards.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding the transactions of company insiders.
  • It assures stakeholders that compensation practices are being disclosed in accordance with regulations.

Key Dates

DateDescription
05/16/2025Date of transaction: acquisition and disposal of common stock.
05/20/2025Date of signature on the Form 4 filing.
06/30/2025First quarterly vesting date for restricted stock units.
09/30/2025Second quarterly vesting date for restricted stock units.
12/31/2025Third quarterly vesting date for restricted stock units.
03/31/2026Final quarterly vesting date for restricted stock units.

Keywords

Form 4, Beneficial Ownership, Director, YCBD, cbdMD, Inc., Stock Acquisition, Stock Disposal, Restricted Stock Units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.